BMRN ridiculous Morningstar analyst target price!
Morningstar weekly highlights set Biomarin Pharmaceuticals with an amazing $119 fair price value (50% above current price).
- Rating: 4 stars
- Uncertainty rating: Medium
- Moat: Narrow
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.